BusinessPCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San DiegoBy Nasdaq OMXFeb 27, 2018, 2:15 PM UTC
BusinessAXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid MoleculesBy Nasdaq OMXFeb 27, 2018, 2:02 PM UTC
BusinessPCI Synthesis Submits Patent for Synthesizing Azelaic AcidBy Nasdaq OMXJan 30, 2018, 2:15 PM UTC
BusinessPCI Synthesis’ Ed Price Joins SOCMA’s Board of GovernorsBy Nasdaq OMXJan 11, 2018, 2:15 PM UTC
BusinessPCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018By Nasdaq OMXDec 18, 2017, 2:15 PM UTC
BusinessScott VanderWel Joins PCI Synthesis as Business Development ManagerBy Nasdaq OMXNov 15, 2017, 3:15 PM UTC
BusinessLearnaboutgmp LLC Announces the Release of Their Redesigned Award Winning Social Platform Askaboutgmp.comBy Nasdaq OMXFeb 9, 2016, 6:00 PM UTC
